23:2 Diyne PC [DC(8,9)PC]

LIPIDS

CAT No.# CS-CC-00216
Category Lipids
CAS 76078-28-9
Stock Status
AVAILABLE ENQUIRE NOW

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 914.28
Molecular Formula C54H92NO8P
Synonyms: (R)-2,3-bis(tricosa-10,12-diynoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate
Application Notes: The photopolymerization of diacetylenic lipids is topotactic, thus the rate of polymerization depends strongly upon the correct alignment of the acetylenic monomer units. Efficient photopolymerization can only be achieved if the diacetylenic hydrocarbon.
References: Punnamaraju S, You H, Steckl AJ. (2012) Triggered Release of Molecules across Droplet Interface Bilayer Lipid Membranes using Photopolymerizable Lipids. Langmuir. 2012 May 1. [Epub ahead of print]
Shipping: Free Shipping for worldwide on order above 2000 USD
23:2 Diyne PC [DC(8,9)PC] Worldwide Suppliers of 23:2 Diyne PC [DC(8,9)PC] Lipids Clearsynth CS-CC-00216

Product rating: 9 23:2 Diyne PC [DC(8,9)PC] based on 20 ratings

  1. Lipids
  2. 23:2 Diyne PC [DC(8,9)PC]


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. Aripiprazole (1042634)
20. 2-(p-Tolyl)pyrimidine


This page contains information about 23:2 Diyne PC [DC(8,9)PC] Cas 76078-28-9 and its Lipids.

23:2 Diyne PC [DC(8,9)PC] 23:2 Diyne PC [DC(8,9)PC] Worldwide Suppliers of 23:2 Diyne PC [DC(8,9)PC] Lipids Clearsynth 76078-28-9

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."